Advertisement

Physician centred imaging interpretation is dying out — why should I be a nuclear medicine physician?

  • Roland HustinxEmail author
Review Article
  • 57 Downloads
Part of the following topical collections:
  1. Advanced Image Analyses (Radiomics and Artificial Intelligence)

Abstract

Radiomics, machine learning, and, more generally, artificial intelligence (AI) provide unique tools to improve the performances of nuclear medicine in all aspects. They may help rationalise the operational organisation of imaging departments, optimise resource allocations, and improve image quality while decreasing radiation exposure and maintaining qualitative accuracy. There is already convincing data that show AI detection, and interpretation algorithms can perform with equal or higher diagnostic accuracy in various specific indications than experts in the field. Preliminary data strongly suggest that AI will be able to process imaging data and information well beyond what is visible to the human eye, and it will be able to integrate features to provide signatures that may further drive personalised medicine. As exciting as these prospects are, they currently remain essentially projects with a long way to go before full validation and routine clinical implementation. AI uses a language that is totally unfamiliar to nuclear medicine physicians, who have not been trained to manage the highly complex concepts that rely primarily on mathematics, computer sciences, and engineering. Nuclear medicine physicians are mostly familiar with biology, pharmacology, and physics, yet, considering the disruptive nature of AI in medicine, we need to start acquiring the knowledge that will keep us in the position of being actors and not merely witnesses of the wonders developed by other stakeholders in front of our incredulous eyes. This will allow us to remain a useful and valid interface between the image, the data, and the patients and free us to pursue other, one might say nobler tasks, such as treating, caring and communicating with our patients or conducting research and development.

Keywords

Artificial intelligence Radiomics Nuclear medicine Molecular imaging 

Notes

Acknowledgements

The author expresses his gratitude toward Dr. Nadia Withofs for fruitful discussion, and John Bean, for text editing.

Compliance with ethical standards

Conflict of interest

The author has received a speaker honorarium from GE Healthcare, outside the scope of this manuscript.

There is no other conflict of interest.

References

  1. 1.
    Harvey HB, Liu C, Ai J, Jaworsky C, Guerrier CE, Flores E, et al. Predicting no-shows in radiology using regression modeling of data available in the electronic medical record. J Am Coll Radiol. 2017;14:1303–9.CrossRefGoogle Scholar
  2. 2.
    Li X, Wang J, Fung RYK. Approximate dynamic programming approaches for appointment scheduling with patient preferences. Artif Intell Med. 2018;85:16–25.CrossRefGoogle Scholar
  3. 3.
    Marella WM, Sparnon E, Finley E. Screening electronic health record-related patient safety reports using machine learning. J Patient Saf. 2017;13:31–6.CrossRefGoogle Scholar
  4. 4.
    Wang Y, Yu B, Wang L, Zu C, Lalush DS, Lin W, et al. 3D conditional generative adversarial networks for high-quality PET image estimation at low dose. Neuroimage. 2018;174:550–62.CrossRefGoogle Scholar
  5. 5.
    Liu F, Jang H, Kijowski R, Zhao G, Bradshaw T, McMillan AB. A deep learning approach for (18)F-FDG PET attenuation correction. EJNMMI Phys. 2018;5:24.CrossRefGoogle Scholar
  6. 6.
    Petersen H, Holdgaard PC, Madsen PH, Knudsen LM, Gad D, Gravergaard AE, et al. FDG PET/CT in cancer: comparison of actual use with literature-based recommendations. Eur J Nucl Med Mol Imaging. 2016;43:695–706.CrossRefGoogle Scholar
  7. 7.
    Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roque IFM. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014:CD009519.Google Scholar
  8. 8.
    Helsen N, Van den Wyngaert T, Carp L, Stroobants S. FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance. Eur J Nucl Med Mol Imaging. 2018;45:1063–71.CrossRefGoogle Scholar
  9. 9.
    Jaarsma C, Leiner T, Bekkers SC, Crijns HJ, Wildberger JE, Nagel E, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2012;59:1719–28.CrossRefGoogle Scholar
  10. 10.
    Huang JY, Huang CK, Yen RF, Wu HY, Tu YK, Cheng MF, et al. Diagnostic performance of attenuation-corrected myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. J Nucl Med. 2016;57:1893–8.CrossRefGoogle Scholar
  11. 11.
    Nudi F, Iskandrian AE, Schillaci O, Peruzzi M, Frati G, Biondi-Zoccai G. Diagnostic accuracy of myocardial perfusion imaging with CZT technology: systemic review and meta-analysis of comparison with invasive coronary angiography. JACC Cardiovasc Imaging. 2017;10:787–94.CrossRefGoogle Scholar
  12. 12.
    Ehteshami Bejnordi B, Veta M, Johannes van Diest P, van Ginneken B, Karssemeijer N, Litjens G, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast Cancer. JAMA. 2017;318:2199–210.CrossRefGoogle Scholar
  13. 13.
    Nishio M, Sugiyama O, Yakami M, Ueno S, Kubo T, Kuroda T, et al. Computer-aided diagnosis of lung nodule classification between benign nodule, primary lung cancer, and metastatic lung cancer at different image size using deep convolutional neural network with transfer learning. PLoS One. 2018;13:e0200721.CrossRefGoogle Scholar
  14. 14.
    Artzi M, Bressler I, Ben Bashat D. Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis. J Magn Reson Imaging. 2019.  https://doi.org/10.1002/jmri.26643.
  15. 15.
    Gao X, Chu C, Li Y, Lu P, Wang W, Liu W, et al. The method and efficacy of support vector machine classifiers based on texture features and multi-resolution histogram from (18)F-FDG PET-CT images for the evaluation of mediastinal lymph nodes in patients with lung cancer. Eur J Radiol. 2015;84:312–7.CrossRefGoogle Scholar
  16. 16.
    Blanc-Durand P, Van Der Gucht A, Schaefer N, Itti E, Prior JO. Automatic lesion detection and segmentation of 18F-FET PET in gliomas: a full 3D U-Net convolutional neural network study. PLoS One. 2018;13:e0195798.CrossRefGoogle Scholar
  17. 17.
    Choi H, Jin KH. Alzheimer’s disease neuroimaging I. predicting cognitive decline with deep learning of brain metabolism and amyloid imaging. Behav Brain Res. 2018;344:103–9.CrossRefGoogle Scholar
  18. 18.
    Kim DH, Wit H, Thurston M. Artificial intelligence in the diagnosis of Parkinson’s disease from ioflupane-123 single-photon emission computed tomography dopamine transporter scans using transfer learning. Nucl Med Commun. 2018;39:887–93.CrossRefGoogle Scholar
  19. 19.
    Shibutani T, Nakajima K, Wakabayashi H, Mori H, Matsuo S, Yoneyama H, et al. Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT. Ann Nucl Med. 2019;33:86–92.CrossRefGoogle Scholar
  20. 20.
    Cronin P, Dwamena BA, Kelly AM, Carlos RC. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology. 2008;246:772–82.CrossRefGoogle Scholar
  21. 21.
    Ruilong Z, Daohai X, Li G, Xiaohong W, Chunjie W, Lei T. Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis. Nucl Med Commun. 2017;38:67–75.CrossRefGoogle Scholar
  22. 22.
    Schwyzer M, Ferraro DA, Muehlematter UJ, Curioni-Fontecedro A, Huellner MW, von Schulthess GK, et al. Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - initial results. Lung Cancer. 2018;126:170–3.CrossRefGoogle Scholar
  23. 23.
    Karantanis D, Kalkanis D, Czernin J, Herrmann K, Pomykala KL, Bogsrud TV, et al. Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians. J Nucl Med. 2014;55:1925–9.CrossRefGoogle Scholar
  24. 24.
    Wu AW, Cavanaugh TA, McPhee SJ, Lo B, Micco GP. To tell the truth: ethical and practical issues in disclosing medical mistakes to patients. J Gen Intern Med. 1997;12:770–5.CrossRefGoogle Scholar
  25. 25.
    Pinto A, Brunese L, Pinto F, Reali R, Daniele S, Romano L. The concept of error and malpractice in radiology. Semin Ultrasound CT MR. 2012;33:275–9.CrossRefGoogle Scholar
  26. 26.
    Degnan AJ, Ghobadi EH, Hardy P, Krupinski E, Scali EP, Stratchko L, et al. Perceptual and interpretive error in diagnostic radiology-causes and potential solutions. Acad Radiol. 2019;26(6):833–845.  https://doi.org/10.1016/j.acra.2018.11.006.
  27. 27.
    Balint BJ, Steenburg SD, Lin H, Shen C, Steele JL, Gunderman RB. Do telephone call interruptions have an impact on radiology resident diagnostic accuracy? Acad Radiol. 2014;21:1623–8.CrossRefGoogle Scholar
  28. 28.
    Nishikawa RM, Schmidt RA, Linver MN, Edwards AV, Papaioannou J, Stull MA. Clinically missed cancer: how effectively can radiologists use computer-aided detection? AJR Am J Roentgenol. 2012;198:708–16.CrossRefGoogle Scholar
  29. 29.
    Iyer RS, Swanson JO, Otto RK, Weinberger E. Peer review comments augment diagnostic error characterization and departmental quality assurance: 1-year experience from a children’s hospital. AJR Am J Roentgenol. 2013;200:132–7.CrossRefGoogle Scholar
  30. 30.
    Wolf M, Krause J, Carney PA, Bogart A, Kurvers RH. Collective intelligence meets medical decision-making: the collective outperforms the best radiologist. PLoS One. 2015;10:e0134269.CrossRefGoogle Scholar
  31. 31.
    Geijer H, Geijer M. Added value of double reading in diagnostic radiology, a systematic review. Insights Imaging. 2018;9:287–301.CrossRefGoogle Scholar
  32. 32.
    Ulaner GA, Mannelli L, Dunphy M. Value of second-opinion review of outside institution PET-CT examinations. Nucl Med Commun. 2017;38:306–11.CrossRefGoogle Scholar
  33. 33.
    Kuhl CK, Alparslan Y, Schmoee J, Sequeira B, Keulers A, Brummendorf TH, et al. Validity of RECIST version 1.1 for response assessment in metastatic cancer: a prospective, multireader study. Radiology. 2019;290:349–56.CrossRefGoogle Scholar
  34. 34.
    Garcia EV, Klein JL, Moncayo V, Cooke CD, Del’Aune C, Folks R, et al. Diagnostic performance of an artificial intelligence-driven cardiac-structured reporting system for myocardial perfusion SPECT imaging. J Nucl Cardiol. 2018.  https://doi.org/10.1007/s12350-018-1432-3.
  35. 35.
    Panayides AS, Pattichis M, Leandrou S, Pitris C, Constantinidou A, Pattichis CS. Radiogenomics for precision medicine with a big data analytics perspective. IEEE J Biomed Health Inform. 2018.  https://doi.org/10.1109/JBHI.2018.2879381.
  36. 36.
    Pinker K, Chin J, Melsaether AN, Morris EA, Moy L. Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment. Radiology. 2018;287:732–47.CrossRefGoogle Scholar
  37. 37.
    Jackson P, Hardcastle N, Dawe N, Kron T, Hofman MS, Hicks RJ. Deep learning renal segmentation for fully automated radiation dose estimation in unsealed source therapy. Front Oncol. 2018;8:215.CrossRefGoogle Scholar
  38. 38.
    Kirienko M, Cozzi L, Rossi A, Voulaz E, Antunovic L, Fogliata A, et al. Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions. Eur J Nucl Med Mol Imaging. 2018;45:1649–60.CrossRefGoogle Scholar
  39. 39.
    Hsu CY, Doubrovin M, Hua CH, Mohammed O, Shulkin BL, Kaste S, et al. Radiomics features differentiate between normal and tumoral high-Fdg uptake. Sci Rep. 2018;8:3913.CrossRefGoogle Scholar
  40. 40.
    Deist TM, Dankers F, Valdes G, Wijsman R, Hsu IC, Oberije C, et al. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: an empirical comparison of classifiers. Med Phys. 2018;45:3449–59.CrossRefGoogle Scholar
  41. 41.
    Callister ME, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax. 2015;70(Suppl 2):ii1–ii54.CrossRefGoogle Scholar
  42. 42.
    Herder GJ, van Tinteren H, Golding RP, Kostense PJ, Comans EF, Smit EF, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest. 2005;128:2490–6.CrossRefGoogle Scholar
  43. 43.
    McWilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013;369:910–9.CrossRefGoogle Scholar
  44. 44.
    Hainc N, Federau C, Stieltjes B, Blatow M, Bink A, Stippich C. The bright, artificial intelligence-augmented future of neuroimaging reading. Front Neurol. 2017;8:489.CrossRefGoogle Scholar
  45. 45.
    Chan S, Siegel EL. Will machine learning end the viability of radiology as a thriving medical specialty? Br J Radiol. 2019;92:20180416.CrossRefGoogle Scholar
  46. 46.
    Hall M. Artificial intelligence and nuclear medicine. Nucl Med Commun. 2019;40:1–2.Google Scholar
  47. 47.
    Miotto R, Li L, Kidd BA, Dudley JT. Deep patient: an unsupervised representation to predict the future of patients from the electronic health records. Sci Rep. 2016;6:26094.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Nuclear Medicine and Oncological ImagingUniversity Hospital of LiègeLiègeBelgium
  2. 2.GIGA-CRC in vivo ImagingUniversity of LiègeLiègeBelgium

Personalised recommendations